Louis Flaspohler
Rheumatology · Cincinnati, OHNPI 1629061569
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,101 and has fallen 86.3% since, to $151 in 2023. That places this record below the midpoint for rheumatology clinicians in OH, where the typical reported total is $1,245.
Across 130 payments — averaging $12.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$336
- Amgen$334
- Lilly USA, LLC$216
- UCB, Inc.$143
- Novartis$143
- Bristol Myers Squibb$112
- plus $379 from 11 others
What the payments were for
- Food & beverage$1,63698%
- Education$272%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $336 |
| Amgen(2 entities) | 24 | $334 |
| Lilly USA, LLC | 22 | $216 |
| UCB, Inc. | 11 | $143 |
| Novartis | 11 | $143 |
| Bristol Myers Squibb | 14 | $112 |
| E.r. Squibb & Sons, L.L.C. | 5 | $80 |
| Pfizer | 4 | $69 |
| Hikma Pharmaceuticals USA | 3 | $41 |
| Boehringer Ingelheim | 2 | $33 |
| Sobi, Inc | 2 | $30 |
| GSK | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Octapharma USA, Inc. | 1 | $21 |
| Radius Health, Inc. | 1 | $17 |
| Johnson & Johnson | 2 | $16 |
How this compares
$1,663 in reported general payments places this provider in the 50th percentile of 255 rheumatology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 13 | $518,203 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 12 | $315,125 |
| Hydroxychloroquine Sulfate | 141 | $3,987 |
| Leflunomide | 22 | $2,828 |
| Prednisone | 170 | $1,764 |
| MethotrexateMethotrexate Sodium | 66 | $1,528 |
| Sulfasalazine | 23 | $654 |
| Azathioprine | 15 | $651 |
| Celecoxib | 12 | $251 |
| Naproxen | 24 | $223 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $187 |
| Meloxicam | 29 | $164 |
| Folic Acid | 11 | $86 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Cincinnati
- Gregory DelorenzoCincinnati$1.3M
- Robert HiltzCincinnati$165K
- David GreenblattCincinnati$56K
- Michael LuggenCincinnati$13K
- Emily BowersCincinnati$10K
- John HarleyCincinnati$9K
- Leonard CalabreseCleveland$1.9M
- Alexa MearaColumbus$426K
- Chad DealCleveland$375K
- David MandelMayfield Village$352K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.